Prescription Omega-3 EPA Tied to Longer Survival After Colorectal Cancer Liver Surgery in Preliminary Trial
A U.K. phase 3 trial linked prescription EPA with higher five-year survival after surgery for colorectal cancer liver metastases, but it did not improve progression-free survival.
Medical Daily ·